WS
WSE
Wise Group plc
$10.84
-3.13%
$13.4B
No data for this timeframe.
Vol
Market Cap$13.4B
Cap SizeLarge Cap
SEC Reports6
Recent Activity
Jun 2, 2026
short_volume
Short Volume: WSE — 71.5% short (0.5M / 0.7M)
Short: 481,770 | Exempt: 13,186 | TRF Vol: 673,990 | Short Ratio: 71.5% | Off-exchange volume (dark
Jun 1, 2026
SEC
Wise Group plc filed a 6-K responding to press articles about an ongoing inquiry by the Brussels prosecutor into its bus
6-K — Impact 6/10
May 27, 2026
Event
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Class I: Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureu
May 11, 2026
SEC
Wise Group plc announces its US listing on Nasdaq effective May 11, 2026, alongside strong FY2026 preliminary unaudited
6-K — Impact 7/10
May 8, 2026
SEC
David B. Wells filed a Form 3 initial statement of beneficial ownership reporting 500,000 stock options in Wise Group pl
3 — Impact 2/10
Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$17.17
Current $10.57
Low $16.00
Median $16.50
High $19.00
3 analysts
$16.00
$19.00
Analyst Ratings
6Strong Buy
13Buy
4Hold
1Sell
1Strong Sell
Earnings Estimates
| Period | EPS Est. | Range | Growth | # |
|---|---|---|---|---|
| Current FY | $0.48 | $0.46 — $0.50 | 3 | |
| Next FY | $0.57 | $0.56 — $0.60 | 20% YoY | 3 |
Latest Reports
No institutional holding data available yet. Data is sourced from 13F filings which are filed quarterly.
No insider trading data available yet. Insider transactions are collected from SEC Form 4 filings.
6 SEC filing reports analyzed. Sentiment: 1 bullish, 1 bearish, 0 mixed, 4 neutral. Avg impact: 3.5/10.
BEARISH
6-K
6/10
Wise Group plc filed a 6-K responding to press articles about an ongoing inquiry by the Brussels pro
Jun 1, 2026
BULLISH
6-K
7/10
Wise Group plc announces its US listing on Nasdaq effective May 11, 2026, alongside strong FY2026 pr
May 11, 2026
NEUTRAL
3
2/10
David B. Wells filed a Form 3 initial statement of beneficial ownership reporting 500,000 stock opti
May 8, 2026
NEUTRAL
3
2/10
Scott Anthony Hill filed a Form 3 initial statement of beneficial ownership with Wise Group plc, ind
May 8, 2026
NEUTRAL
3
2/10
Form 3 filed for Elizabeth Grace Chambers, an insider (officer/director) of Wise Group plc. This is
May 8, 2026
NEUTRAL
3
2/10
Alastair Rampell filed a Form 3 initial statement of beneficial ownership, reporting 1,075,532 Class
May 8, 2026
No press releases analyzed yet. Press releases are collected from GlobeNewsWire and analyzed by the LLM pipeline.
Historical analyst distribution: 76% buy across 25 analysts — 6 strong buy, 13 buy, 4 hold, 1 sell, 1 strong sell. No current recommendation available.
Analyst Price Targets
No recent covering-analyst activity on file. No current recommendation available.
$17.17 mean target
$16.00 Low
$19.00 High
| Metric | Value |
|---|---|
| Current Price | $10.57 |
| Target Low | $16.00 |
| Target Mean | $17.17 |
| Target Median | $16.50 |
| Target High | $19.00 |
| # Analysts | 3 |
| Recommendation | — (no recent coverage) |
Earnings Estimates & Revisions
| Period | EPS Avg | EPS Low | EPS High | EPS Growth | 30d Rev. | Up/Down | Rev. Avg | Rev. Growth | Analysts |
|---|---|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Next Q | $0.00 | $0.00 | $0.00 | — | — | — | $0.0B | — | — |
| Current FY 2026-03-31 |
$0.48 | $0.46 | $0.50 | — | — | — | $1.9B | 13.6% | 3 |
| Next FY 2027-03-31 |
$0.57 | $0.56 | $0.60 | 20.3% | — | — | $2.2B | 16.1% | 3 |
Monthly Consensus History
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | 6 | 13 | 4 | 1 | 1 | 76% | |
| May 1, 2026 | 5 | 14 | 4 | 1 | 1 | 76% | |
| Apr 1, 2026 | 5 | 14 | 4 | 1 | 1 | 76% | |
| Mar 1, 2026 | 5 | 15 | 4 | 0 | 1 | 80% |
Strong BuyBuyHoldSellStrong Sell
No congressional trading data available for this ticker. Data is sourced from Senate and House financial disclosure filings.
Recent Reddit Threads
CEREBRAS IPO 14th MAY’26 . Priced at ~ $150-$160/share.
▲ 1
💬 1
⚡ 0.5
Jun 2, 2026
short_volume
Short Volume: WSE — 71.5% short (0.5M / 0.7M)
Short: 481,770 | Exempt: 13,186 | TRF Vol: 673,990 | Short Ratio: 71.5% | Off-exchange volume (dark pool + OTC)
Jun 1, 2026
short_volume
Short Volume: WSE — 73.3% short (1.2M / 1.6M)
Short: 1,166,583 | Exempt: 64,293 | TRF Vol: 1,591,232 | Short Ratio: 73.3% | Off-exchange volume (dark pool + OTC)
May 27, 2026
FDA
MG217 Multi-Symptom Treatment Cream & Skin Protectant (colloidal oatmeal 2%), NET WT 6 oz (170 g), Manufactured by: Pharmacal 1 Pharmacal Way, P.O. Box 198, Jackson, WI 53037.
Class I: Microbial Contamination of Non-Sterile Products: confirmed presence of Staphylococcus Aureus.
May 13, 2026
short_interest
FTD: WSE — 209,864 shares ($3.0M) failed to deliver
Settlement: 20260513, Price: $14.17, FTD Value: $2,973,772.88, WISE GROUP PLC CL A (JEY)
May 12, 2026
short_volume
Short Volume: WSE — 80.7% short (0.5M / 0.6M)
Short: 485,951 | Exempt: 15,674 | TRF Vol: 602,372 | Short Ratio: 80.7% | Off-exchange volume (dark pool + OTC)
May 12, 2026
short_interest
FTD: WSE — 88,786 shares ($1.4M) failed to deliver
Settlement: 20260512, Price: $15.40, FTD Value: $1,367,304.4, WISE GROUP PLC CL A (JEY)
May 11, 2026
other
Wise debuts US listing on Nasdaq
Wise debuts US listing on Nasdaq